A Successful Global Trial Paves the Way for the US FDA Approval of the First-in-Class Gonorrhoea Antibiotic

A major milestone in global health has been achieved with the U.S. FDA approval of NUZOLVENCE® (zoliflodacin), the first new antibiotic developed exclusively for the treatment of gonorrhoea in decades.

Positive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to Treat Drug-Resistant Gonorrhea

ผลลัพธ์เชิงบวกจากโครงการวิจัยระยะ 3 ที่ใหญ่สุดของยาปฏิชีวนะชนิดรับประทาน ประเภท First-In-Class เพื่อรักษาโรคหนองในดื้อยา

MOU signing ceremony between GARDP and the Faculty of Medicine Siriraj Hospital

Welcome to MOU signing ceremony between GARDP and the Faculty of Medicine Siriraj Hospital on 28th February 2023